-
- Topic
- Voices
- Posts
- Last Post
-
-
Sex & MS – Yes, I Said It!
Started by:
in: Living With MS
- 1
- 1
- 3 hours, 10 minutes ago
-
Brain Changes in Relapsing MS Found to Follow Pattern
Started by:
in: Treatments and Trials
- 1
- 1
- 4 days, 2 hours ago
-
FDA Approves Shorter Infusion Time for MS Therapy Ocrevus
Started by:
in: Treatments and Trials
- 0
- 1
- 4 days, 22 hours ago
-
Tecfidera May Be Effective Option for Relapsing MS Patients Who Fail to Respond to Glatiramer Acetate
Started by:
in: Treatments and Trials
- 1
- 1
- 1 week ago
-
Can I Get a COVID-19 Vaccine If I Have MS?
Started by:
in: Living With MS
- 0
- 1
- 1 week, 2 days ago
-
Public-private Partnership Will Assess Therapy Potential, Effects of CBD
Started by:
in: Alternative Treatments
- 1
- 1
- 1 week, 4 days ago
-
Amazon tried to lower its employees’ healthcare costs. Did it work?
Started by:
in: Living With MS
- 1
- 1
- 1 week, 4 days ago
-
Cognitive Fatigue in MS Patients May Impair Motor Function, Study Finds
Started by:
in: Living With MS
- 0
- 1
- 1 week, 5 days ago
-
MS Risk May Be Higher for Children With Diabetic Mothers, Study Says
Started by:
in: Treatments and Trials
- 0
- 1
- 1 week, 6 days ago
-
How I Weirdly Found a New Solution to Dealing with Trigeminal Neuralgia [TG]
Started by:
in: Living With MS
- 1
- 1
- 2 weeks ago
-
Boosting Cholesterol Recycling in Brain May Facilitate MS Myelin Repair
Started by:
in: Treatments and Trials
- 0
- 1
- 2 weeks, 3 days ago
-
Plegridy as Intramuscular Injection for RRMS Approved in Europe
Started by:
in: Treatments and Trials
- 0
- 1
- 2 weeks, 5 days ago
-
Caroline Wyatt: MS research ‘the urgent search for hope’
Started by:
in: Treatments and Trials
- 1
- 1
- 1 month ago
-
Insurance
Started by:
in: Newly Diagnosed
- 1
- 1
- 1 month ago
-
Mavenclad
Started by:
in: MS Drugs
- 1
- 1
- 1 month, 1 week ago
-
Sex & MS – Yes, I Said It!
Newest Topics
-
Sex & MS – Yes, I Said It!
by
-
In the UK MS Patients Have been Refused a Blue Badge [Disabled Placards]
by
-
Brain Changes in Relapsing MS Found to Follow Pattern
by
-
FDA Approves Shorter Infusion Time for MS Therapy Ocrevus
by
-
Tecfidera May Be Effective Option for Relapsing MS Patients Who Fail to Respond to Glatiramer Acetate
by
